NASDAQ:AMIX Autonomix Medical (AMIX) Stock Price, News & Analysis $5.32 -0.31 (-5.51%) As of 08/28/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOwnershipSEC Filings About Autonomix Medical Stock (NASDAQ:AMIX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Autonomix Medical alerts:Sign Up Key Stats Today's Range$5.08▼$5.6150-Day Range$2.75▼$19.5052-Week Range$2.44▼$32.55Volume311,995 shsAverage Volume9.36 million shsMarket Capitalization$5.16 millionP/E RatioN/ADividend YieldN/APrice Target$42.00Consensus RatingHold Company Overview Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas. Read More Autonomix Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks66th Percentile Overall ScoreAMIX MarketRank™: Autonomix Medical scored higher than 66% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingAutonomix Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialAutonomix Medical has a consensus price target of $42.00, representing about 689.5% upside from its current price of $5.32.Amount of Analyst CoverageAutonomix Medical has only been the subject of 2 research reports in the past 90 days.Read more about Autonomix Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Autonomix Medical are expected to grow in the coming year, from ($20.17) to ($17.44) per share.Price to Book Value per Share RatioAutonomix Medical has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Autonomix Medical's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted11.94% of the float of Autonomix Medical has been sold short.Short Interest Ratio / Days to CoverAutonomix Medical has a short interest ratio ("days to cover") of 0.01, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Autonomix Medical has recently decreased by 58.70%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAutonomix Medical does not currently pay a dividend.Dividend GrowthAutonomix Medical does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.90 News SentimentAutonomix Medical has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Autonomix Medical this week, compared to 3 articles on an average week.Search Interest14 people have searched for AMIX on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows3 people have added Autonomix Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Autonomix Medical insiders have not sold or bought any company stock.Percentage Held by Insiders6.20% of the stock of Autonomix Medical is held by insiders.Percentage Held by Institutions10.78% of the stock of Autonomix Medical is held by institutions.Read more about Autonomix Medical's insider trading history. Receive AMIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Autonomix Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AMIX Stock News HeadlinesAutonomix Medical (NASDAQ:AMIX) Cut to "Strong Sell" at Wall Street ZenAugust 29 at 1:11 AM | americanbankingnews.comAutonomix Medical Completes Warrant-Induced Capital RaiseAugust 26, 2026 | tipranks.comWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.August 30 at 1:00 AM | Awesomely (Ad)Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy DeliveryAugust 26, 2026 | globenewswire.comAutonomix Medical more than doubles after $4.9M warrant deal; shares hit $11.63August 25, 2026 | msn.comAutonomix Medical Announces $4.9 Million Warrant Inducement Agreement to Exercise July 2026 WarrantsAugust 24, 2026 | quiverquant.comQAutonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq RulesAugust 24, 2026 | globenewswire.comAutonomix Medical Completes GLP Pre-Clinical Study, Advancing FDA Submission August 12, 2026 | quiverquant.comQSee More Headlines AMIX Stock Analysis - Frequently Asked Questions How have AMIX shares performed this year? Autonomix Medical's stock was trading at $11.55 at the beginning of 2026. Since then, AMIX shares have decreased by 53.9% and is now trading at $5.32. How were Autonomix Medical's earnings last quarter? Autonomix Medical, Inc. (NASDAQ:AMIX) released its quarterly earnings results on Wednesday, August, 12th. The company reported ($5.02) earnings per share for the quarter, beating the consensus estimate of ($6.40) by $1.38. When did Autonomix Medical's stock split? Autonomix Medical's stock reverse split before market open on Wednesday, June 24th 2026.A 1-21 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 23rd 2026. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did Autonomix Medical IPO? Autonomix Medical (AMIX) raised $11 million in an IPO on the week of January 29th 2024. The company issued 2,234,222 shares at a price of $5.00 per share. How do I buy shares of Autonomix Medical? Shares of AMIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Autonomix Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Autonomix Medical investors own include Advanced Micro Devices (AMD), Luminar Technologies (LAZR), New Found Gold (NFGC), Tesla (TSLA), Global X Artificial Intelligence & Technology ETF (AIQ), Aldeyra Therapeutics (ALDX) and Allegro MicroSystems (ALGM). Company Calendar Last Earnings8/12/2026Today8/30/2026Next Earnings (Estimated)11/11/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2w+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 For the last 2 weeks, AMIX's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:AMIX Previous SymbolNASDAQ:AMIX CIK1617867 Webautonomix.com Phone713-588-6150FaxN/AEmployees1Year FoundedN/APrice Target and Rating Average Price Target for Autonomix Medical$42.00 High Price Target$42.00 Low Price Target$42.00 Potential Upside/Downside+689.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($41.57) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$16.72 million Net MarginsN/A Pretax MarginN/A Return on Equity-267.73% Return on Assets-216.75% Debt Debt-to-Equity RatioN/A Current Ratio4.85 Quick Ratio4.85 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$10.85 per share Price / Book0.49Miscellaneous Outstanding Shares970,000Free Float911,000Market Cap$5.16 million OptionableN/A Beta-1.16 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:AMIX) was last updated on 8/30/2026 by MarketBeat.com Staff. From Our PartnersThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredWhy Boston Ships In Natural Gas It Already Has at HomeA tanker called the Iberica Knutsen once sailed 2,272 miles from Trinidad and Tobago to deliver liquefied natu...Porter & Company | SponsoredSPDR Gold just lost $14 billion.Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...Behind the Markets | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredHe called Apple then saw 12,000%+ gains. Now he's pointing at THIS.In 1999, George Gilder predicted phones would outpower desktop computers. Apple's iPhone followed, and the sto...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
